Genscreen announces the completion of the formation of Trobio Pty Ltd and the partnership with the tropomyosin technology of Professor Peter Gunning. Professor Gunning has agreed to be a member of the Trobio Scientific Advisory Panel, along with Associate Professor Mark Smith and Dr Ricky Johnstone.
Trobio Pty Ltd is a subsidiary of Genscreen Pty Ltd. The CEO of Genscreen, Ian Dixon, announced that Trobio was an exciting addition to the existing portfolio of Genscreen; and represented a significant opportunity for a drug development project to progress towards a Phase II trial and eventual partnership with an international partner.